Celldex Therapeutics (CLDX) Tax Rate (2017 - 2021)

Celldex Therapeutics (CLDX) recorded quarterly Tax Rate of 1.1% in Q3 2021, up 127.86% quarter-over-quarter from 3.94% in Q4 2020.

Celldex Therapeutics (CLDX) Tax Rate (2017 - 2021) Analysis & Trends

Celldex Therapeutics' Tax Rate history runs 4 years deep, the most recent figure standing at 1.1% for Q3 2021.

In Q3 2021, Tax Rate changed N/A year-over-year to 1.1%; the TTM figure through Dec 2021 stood at 0.95% (up 20.0% YoY), while the FY2021 annual figure was 0.32%, down 159.0% from the prior year.
Tax Rate was 1.1% for Q3 2021 at Celldex Therapeutics, up from 3.94% in the prior quarter.
In the past five years, Tax Rate ranged from a high of 83.24% in Q4 2017 to a low of 3.94% in Q4 2020.
Historically, Tax Rate has averaged 14.16% across 4 years, with a median of 1.1% in 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-57.14
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-6.79
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	5.61
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	17.68
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Celldex Therapeutics	2.16 Bn	2.16 Bn	-1.44 Mn	-

Download Data